PTC Therapeutics | PTCT - Ebitda





Ebitda Veränderung Datum
Acadia Pharmaceuticals USD -1.62M 21.94M 2026-03
Alnylam Pharmaceuticals USD 245.34M 59.15M 2026-06
Amgen USD 3.86B 1.28B 2026-03
BioCryst Pharmaceuticals USD 51.7M 30.14M 2025-09
Biogen USD 649.7M 76.5M 2026-03
BioMarin Pharmaceutical USD 146.05M 170.22M 2026-03
Cytokinetics USD -169.32M 19.48M 2026-03
Daiichi Sankyo JPY 101.6B 22.81B 2025-03
Gilead Sciences USD 3.51B 489M 2026-03
Incyte USD 778.57M 410.6M 2026-06
Ionis Pharmaceuticals USD -64.53M 135.49M 2026-03
Ironwood Pharmaceuticals USD 81.81M 31.71M 2025-09
Karyopharm Therapeutics USD -26.2M 1.83M 2024-09
Novartis USD 6.48B 1.19B 2026-06
Pfizer USD 6.01B 18M 2026-06
PTC Therapeutics USD 61.98M 132.97M 2026-03
Puma Biotechnology USD 729K 11.36M 2024-06
Roche Holding CHF 13.43B 744M 2026-06
Sarepta Therapeutics USD 375.48M 627.68M 2026-03
TG Therapeutics USD 28.11M 23.58M 2026-03
Ultragenyx Pharmaceutical USD -155M 55.57M 2026-03
Vertex Pharmaceuticals USD 1.19B 195.3M 2026-03
Xencor USD -34.63M 86.74M 2026-06